• Metal Ion-Mediated Enrichment Boosts mRNA Vaccine Loading an

  2026-06-19

  This study introduces a manganese ion-mediated strategy to substantially increase mRNA loading in lipid nanoparticle vaccines, nearly doubling both loading capacity and cellular uptake compared to conventional formulations. The findings offer a promising route to dose-sparing, reduced toxicity, and improved immunogenicity, with broad implications for mRNA therapeutics.

• Rocilinostat (ACY-1215): Selective HDAC6 Inhibitor for Myelo

  2026-06-19

  Rocilinostat (ACY-1215) is a potent, highly selective HDAC6 inhibitor with an IC50 of 5 nM, disrupting cancer cell functions via α-tubulin acetylation. It demonstrates strong anti-myeloma activity, especially in combination with proteasome inhibitors, and is supplied by APExBIO for research use. Its specificity and DMSO solubility make it a valuable tool for cancer epigenetics research.

• 3-(1-methylpyrrolidin-2-yl)pyridine (N2703) in Cardiac Assay

  2026-06-18

  3-(1-methylpyrrolidin-2-yl)pyridine (N2703) empowers researchers to precisely modulate cellular signaling pathways in advanced cardiac arrhythmia models. Its robust solubility, high purity, and validated action as a molecular probe make it an indispensable, troubleshooting-friendly tool for dissecting neuro-adipose interactions and protein modulation in vitro and in vivo.

• AZD0156: Selective ATM Kinase Inhibitor for Cancer Research

  2026-06-18

  AZD0156 is a potent, orally bioavailable ATM kinase inhibitor with >1000-fold selectivity, enabling precise modulation of DNA double-strand break repair in cancer models. Early studies demonstrate synergistic effects with DNA-damaging agents and highlight roles in checkpoint control modulation. Its robust selectivity and reproducibility make AZD0156 a benchmark tool for DNA damage response research.

• Dual-Action p38α MAPK Inhibitors: Mechanistic Insights and A

  2026-06-17

  The referenced study reveals that certain p38α MAPK inhibitors not only block kinase activity but also accelerate dephosphorylation of the activation loop by stabilizing a phosphatase-accessible conformation. This dual-action mechanism represents a significant advance in selective kinase inhibition, with direct relevance for inflammation and autoimmune research.

• Stiripentol: Precision LDH Inhibition for Translational Rese

  2026-06-17

  Explore how Stiripentol, a novel LDH inhibitor, empowers translational researchers to dissect lactate metabolism, modulate the astrocyte-neuron lactate shuttle, and address challenges in epilepsy and tumor immunometabolism. This thought-leadership piece bridges mechanistic insight with workflow guidance, referencing the latest evidence on lactate-driven epigenetic regulation.

• Pseudo-UTP in mRNA Synthesis: Enhancing Stability and Transl

  2026-06-16

  Pseudo-modified uridine triphosphate (Pseudo-UTP) transforms synthetic mRNA workflows by boosting RNA stability, translation efficiency, and reducing immunogenicity—key for advanced vaccine and gene therapy development. Here, we detail experimental protocols, troubleshooting strategies, and unique insights from current preclinical research to help researchers fully leverage Pseudo-UTP from APExBIO.

• Applied Workflows with Angiotensin 1/2 (5-7) in RAS Research

  2026-06-16

  Angiotensin 1/2 (5-7) empowers precise, reproducible assays in cardiovascular and emerging viral pathogenesis workflows. Leverage its high solubility, validated purity, and recent mechanistic insights to accelerate both hypertension and SARS-CoV-2 research.

• IGF2BP1-m6A-TUBB4B Axis Drives Hepatic Stellate Cell Activat

  2026-06-15

  This study uncovers how the m6A reader IGF2BP1 promotes hepatic stellate cell (HSC) activation by stabilizing TUBB4B mRNA in an m6A-dependent manner, advancing understanding of liver fibrosis mechanisms. Targeting this IGF2BP1/TUBB4B/FAK signaling axis could inform new therapeutic strategies for fibrotic liver disease.

• U 46619: Applied Workflows for Platelet Aggregation & Vascul

  2026-06-15

  U 46619 (11,9 epoxymethano-prostaglandin H2) empowers researchers with precise, reproducible control over platelet and vascular assays, thanks to its selective TP receptor agonism and robust solubility. This guide translates the latest experimental and mechanistic insights into actionable protocols, troubleshooting, and optimization strategies for advanced cardiovascular and renal models.

• Paroxetine Mesylate: Bridging Neurocardiac Biomarkers and Mu

  2026-06-14

  Explore the multifaceted mechanisms of Paroxetine Mesylate, a selective serotonin reuptake inhibitor, and its unique role in neurocardiac biomarker discovery and kinase inhibition. This article provides an advanced perspective on translational research applications and practical assay decisions.

• Tacalcitol Monohydrate Induces NGF in Human Keratinocytes

  2026-06-13

  This article analyzes the seminal study demonstrating that tacalcitol, a synthetic analog of vitamin D3, transcriptionally induces nerve growth factor (NGF) production in human epidermal keratinocytes. The findings provide a mechanistic basis for tacalcitol’s dermatological actions and suggest new translational opportunities for peripheral neuropathy research.

• A-769662: Potent AMPK Activator for Metabolic Research

  2026-06-12

  A-769662 is a reversible small molecule AMPK activator with submicromolar potency. It modulates energy metabolism, inhibits fatty acid synthesis, and produces AMPK-dependent and independent effects. This profile provides verifiable parameters and clarifies misconceptions on its use in metabolic and autophagy studies.

• Primidone (Mysoline): Protocols & Troubleshooting for Transl

  2026-06-12

  Primidone (Mysoline) is redefining neurodegenerative and gynecological research through its dual action on TRPM3 and RIPK1 pathways. This article delivers actionable protocols, troubleshooting insights, and direct comparisons to help researchers maximize reproducibility and data quality across in vitro and in vivo models.

• NHE1 Drives Octanal/Olfr2-Mediated Atherosclerosis in Macrop

  2026-06-11

  This study reveals that sodium-hydrogen exchanger 1 (NHE1) in macrophages acts as a crucial mediator of atherosclerosis progression triggered by octanal-activated Olfr2 signaling. The findings illuminate a calcium-dependent pathway linking odorant receptor signaling to ROS production and inflammasome activation, highlighting NHE1 as a potential therapeutic target in cardiovascular disease.

451 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page